Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Rat Model Market, by Technology
1.4.2 North America Rat Model Market, by Type
1.4.3 North America Rat Model Market, by Service
1.4.4 North America Rat Model Market, by Application
1.4.5 North America Rat Model Market, by End-use
1.4.6 North America Rat Model Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Rat Model Market by Technology
3.1 North America CRISPR/CAS & Others Market by Country
3.2 North America Nuclear transferase Market by Country
3.3 North America Embryonic Stem Cell & Microinjection Market by Country
Chapter 4. North America Rat Model Market by Type
4.1 North America Outbred Market by Country
4.2 North America Hybrid Market by Country
4.3 North America Knockout Market by Country
4.4 North America Inbred Market by Country
4.5 North America Immunodeficient Market by Country
4.6 North America Conditioned Market by Country
Chapter 5. North America Rat Model Market by Service
5.1 North America Breeding Market by Country
5.2 North America Genetic testing Market by Country
5.3 North America Cryopreservation Market by Country
5.4 North America Re-derivation Market by Country
5.5 North America Quarantine Depending & Others Market by Country
Chapter 6. North America Rat Model Market by Application
6.1 North America Toxicology Market by Country
6.2 North America Oncology Market by Country
6.3 North America Immunology Market by Country
6.4 North America Neurology & Others Market by Country
Chapter 7. North America Rat Model Market by End-use
7.1 North America CROs Market by Country
7.2 North America Pharmaceutical & Biotechnology Companies Market by Country
7.3 North America Academic & Research Institutes Market by Country
Chapter 8. North America Rat Model Market by Country
8.1 US Rat Model Market
8.1.1 US Rat Model Market by Technology
8.1.2 US Rat Model Market by Type
8.1.3 US Rat Model Market by Service
8.1.4 US Rat Model Market by Application
8.1.5 US Rat Model Market by End-use
8.2 Canada Rat Model Market
8.2.1 Canada Rat Model Market by Technology
8.2.2 Canada Rat Model Market by Type
8.2.3 Canada Rat Model Market by Service
8.2.4 Canada Rat Model Market by Application
8.2.5 Canada Rat Model Market by End-use
8.3 Mexico Rat Model Market
8.3.1 Mexico Rat Model Market by Technology
8.3.2 Mexico Rat Model Market by Type
8.3.3 Mexico Rat Model Market by Service
8.3.4 Mexico Rat Model Market by Application
8.3.5 Mexico Rat Model Market by End-use
8.4 Rest of North America Rat Model Market
8.4.1 Rest of North America Rat Model Market by Technology
8.4.2 Rest of North America Rat Model Market by Type
8.4.3 Rest of North America Rat Model Market by Service
8.4.4 Rest of North America Rat Model Market by Application
8.4.5 Rest of North America Rat Model Market by End-use
Chapter 9. Company Profiles
9.1 Charles River Laboratories International, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Recent strategies and developments:
9.1.4.1 Acquisition and Mergers:
9.2 Laboratory Corporation of America Holdings
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental Analysis
9.2.4 Recent strategies and developments:
9.2.4.1 Acquisition and Mergers:
9.3 Inotiv, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent strategies and developments:
9.3.5.1 Product Launches and Product Expansions:
9.4 genOway
9.4.1 Company Overview
9.4.2 Financial Analysis
9.5 Janvier Labs
9.5.1 Company Overview
9.6 Taconic Biosciences, Inc. (H.I.G. Capital)
9.6.1 Company Overview
9.7 TransViragen, Inc.
9.7.1 Company Overview
9.8 Biomedical Research Models, Inc. (Biomere)
9.8.1 Company Overview
9.9 Cyagen Biosciences
9.9.1 Company Overview
Unique Offerings 
